Related Experiment Video
Updated: Feb 13, 2026
An Organotypic High Throughput System for Characterization of Drug Sensitivity of Primary Multiple Myeloma Cells
Published on: July 15, 2015
Multiple Myeloma, Version 5.2026, NCCN Clinical Practice Guidelines In Oncology
Shaji K Kumar1, Natalie S Callander2, Kehinde Adekola3
11Mayo Clinic Comprehensive Cancer Center.
Abstract:
The treatment landscape for multiple myeloma (MM) is evolving rapidly and includes several new options. The management must be tailored to the individual. The NCCN Guidelines for MM provide a framework to base decisions regarding diagnosis, workup, treatment, and follow-up of both newly diagnosed and previously treated relapsed/refractory MM. This manuscript outlines the recommendations from NCCN Guidelines for MM specific to newly diagnosed MM (NDMM).
Insights
The multiple myeloma (MM) treatment landscape is rapidly evolving. NCCN Guidelines offer a framework for individualized care in newly diagnosed MM (NDMM).
Area of Science:
- Hematology
- Oncology
- Clinical Practice Guidelines
Background:
- The treatment options for multiple myeloma (MM) are expanding rapidly.
- Individualized patient management is crucial in MM care.
- Existing guidelines require updates to reflect new therapeutic advancements.
Purpose of the Study:
- To outline the National Comprehensive Cancer Network (NCCN) Guidelines recommendations for newly diagnosed multiple myeloma (NDMM).
- To provide a framework for clinical decision-making in NDMM.
- To summarize current evidence-based strategies for NDMM management.
Main Methods:
- Review of the latest NCCN Guidelines for Multiple Myeloma.
- Synthesis of recommendations specific to the diagnosis and treatment of NDMM.
- Focus on evidence-based approaches for initial patient management.
Main Results:
- The NCCN Guidelines provide a structured approach to NDMM diagnosis and workup.
- Key treatment recommendations for NDMM are detailed.
- Guidance on follow-up strategies for NDMM patients is presented.
Conclusions:
- NCCN Guidelines offer essential recommendations for the management of newly diagnosed multiple myeloma.
- These guidelines support tailored treatment strategies based on individual patient factors.
- Adherence to NCCN Guidelines promotes optimal care for NDMM patients.
Related Concept Videos
01:23Guidelines for Sketching a Curve
01:11Guidelines for Writing Outcome
Patient outcomes reflect the patient's response to the goal rather than what the nurse aims to achieve. Terminology should be observable and measurable to avoid the reader's interpretation. The desired outcome should be realistic and achievable in the designated care timeframe. Expected outcomes should align with adjunctive therapies. The outcome should enhance care...
01:30Guidelines for Nursing Documentation I
Factual:
The following points emphasize the significance of upholding accurate and unbiased documentation in healthcare.
01:26Guidelines for Nursing Documentation II
Timely documentation is crucial to ensure continuity of care for patients. Any delays in recording or reporting medical information can result in medical errors and even adverse patient outcomes. From medication administration to diagnostic test results, every detail must be accurately and promptly documented to provide the best possible care for patients.
01:06Legal Guidelines for Documentation
01:18Guidelines and Strategies for Safe Computer Charting
Maintain Confidentiality and Security: